T. Rowe Price Associates’s InnovAge Holding INNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$147K Buy
18,256
+6,757
+59% +$50.5K ﹤0.01% 2920
2025
Q4
$60K Hold
11,499
﹤0.01% 3016
2025
Q3
$60K Buy
11,499
+577
+5% +$2.33K ﹤0.01% 2992
2025
Q2
$41K Buy
+10,922
New +$38.2K ﹤0.01% 3020
2022
Q3
Sell
-5,166,271
Closed -$22.6M 2998
2022
Q2
$22.6M Buy
5,166,271
+257,589
+5% +$1.34M ﹤0.01% 1133
2022
Q1
$31.5M Buy
4,908,682
+3,545,425
+260% +$17.9M ﹤0.01% 1106
2021
Q4
$6.82M Buy
1,363,257
+879,478
+182% +$6.39M ﹤0.01% 1461
2021
Q3
$3.2M Sell
483,779
-957,713
-66% -$14.8M ﹤0.01% 1588
2021
Q2
$30.7M Buy
1,441,492
+237,967
+20% +$5.45M ﹤0.01% 1192
2021
Q1
$31M Buy
+1,203,525
New +$29.6M ﹤0.01% 1166

Other funds holding INNV

T. Rowe Price Associates's INNV Position: Q1 2026 in Review

T. Rowe Price Associates increased its InnovAge Holding (INNV) stake by 59% in Q1 2026, buying an estimated $50.5K and bringing the position to 18,256 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

T. Rowe Price Associates first reported a position in INNV in Q1 2021 and has held it in 10 quarters since. The position peaked at $31.5M in Q1 2022. 103 funds tracked by Wall St. Rank hold INNV as of Q1 2026.

  • T. Rowe Price Associates held 18,256 shares of InnovAge Holding worth $147K as of Q1 2026.
  • T. Rowe Price Associates bought 6,757 InnovAge Holding shares in Q1 2026, an estimated $50.5K.
  • InnovAge Holding made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2920 holding.
  • T. Rowe Price Associates first reported a position in InnovAge Holding in Q1 2021 and has held it in 10 quarters since.
  • T. Rowe Price Associates's InnovAge Holding position peaked at $31.5M in Q1 2022.
  • 103 funds tracked by Wall St. Rank held InnovAge Holding as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.